Intervention Project to Increase Adherence to Colorectal Cancer Screening in Barcelos/Esposende
NCT ID: NCT06972160
Last Updated: 2025-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1038 participants
INTERVENTIONAL
2025-04-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of a Proactive Strategy of General Practitioners on CRC Screening
NCT06664567
Text-based Colorectal Cancer Prevention Pilot
NCT05004376
Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening
NCT04607291
SMS Messaging as a Tool to Improve Cancer Screening Programs
NCT04343950
A Telephone Intervention to Improve Participation in a Screening Program.
NCT03082911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional Group
The interventional group will be subjected to interventions to increase the adherence to screening, including text messages via phone as well as phone calls.
Arm1: intervention 1 (SMS+call)
The intervention will consist in two text messages (one and two weeks after received the screening test, respectively), an automated non-human call or a call made by the administrative assistant (three weeks after received the screening test), and a phone call made by a physician (four weeks after received the screening test)
Control group
The control group will not be subjected to any interventions to increase the adherence to screening.
Control group
The control group will not be subjected to any interventions to increase the adherence to screening.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Arm1: intervention 1 (SMS+call)
The intervention will consist in two text messages (one and two weeks after received the screening test, respectively), an automated non-human call or a call made by the administrative assistant (three weeks after received the screening test), and a phone call made by a physician (four weeks after received the screening test)
Control group
The control group will not be subjected to any interventions to increase the adherence to screening.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Barcelos/Esposende and meet the following criteria:
1. Age between 50 and 74 years.
2. No symptoms such as weight loss in the last 6 months or gastrointestinal symptoms.
3. No prior diagnosis of CRC.
4. No diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease).
5. No family history of CRC in first- and second-degree relatives diagnosed before age 60.
6. No prior fecal occult blood test (FOBT) in the 11 months before receiving the collection kit or no prior sigmoidoscopy or colonoscopy in the last 24 months.
Exclusion Criteria
2. Participants without a phone number.
3. Participants who do not answer the phone or refuse to participate in the study.
4. Participants unable to consent or perform the screening due to physical, mental, or other conditions that seriously impair comprehension.
49 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto de Saude Publica da Universidade do Porto
OTHER
Local Health Unit Barcelos/Esposende, Public Health Unit
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Nascimento Moreira
Public Health Medical Doctor, Local Health Authority
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Public Health Unit Barcelos/Esposende
Porto, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Rede+Rastreio-Cancro
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.